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is not affected by a GST fusion tag. p33 IL-1α had the GST fusion tag specifically cleaved off or was subjected to a 'sham cleavage', and was tested for ability to induce IL-2 from EL4 cells. Data represent mean ±SEM; p = NS; n = 3. 
Supplemental Experimental Procedures
All materials from Sigma-Aldrich unless otherwise stated.
Cell culture
Human aortic VSMCs were isolated from patients with local ethics committee approval. VSMCs, EL4, HEK and HeLa cells were cultured in DMEM and Jurkat, and THP-1 cells in RPMI 1640, all supplemented with 10 U/ml penicillin, 10 mg/ml streptomycin, 5 mg/ml L-glutamine and 10% FCS. VSMCs, HEK, and HeLa cells were cultured to ~80% confluence before passaging. EL-4, Jurkat and THP-1 cells were maintained at 4-10x10 5 cells/ml. Human monocyte-derived macrophages were differentiated as described previously (Brown et al., 2000) . Cells were treated as indicated with; Calpeptin (30µM), Lactacystin (10µM; both Biomol), IL-1α pAb (1µg/ml), IL-1α/β (1nM; all PeproTech), IL-1RA (Amgen), IL-1R2 (250ng; R&D), Z-YVAD, Z-VAD-fmk (both 10µm; Bachem), LPS (1µg/ml), EGTA (5mM), BB-94 (1µg/ml; Tocris). Cells in serum-free DMEM were disrupted by 3 rounds of freeze/thaw in liquid nitrogen in <1ml, clarified (13,000g, 5 mins) and stored at -80°C until use. Cells were also made necrotic by incubation with 7-Bromoindirubin-3'-oxime (25µM; Enzo), pore formation with digitonin (0.1%)(not shown), or overnight hypoxic exposure. To activate inflammasomes, cells were treated with LPS (1µg/ml) for 4 h, followed by ATP (5mM) or Nigericin (20µM) for 30 mins. Calpain enzyme activity was determined using Calpain-Glo according to the manufacturer's instructions (Promega). VSMCs and HEK/THP-1 cells were transfected with pcDNA3 (Invitrogen) using nucleofection (Amaxa) or FugeneHD (Promega), respectively, following the manufacturer's protocols.
Protein expression and purification
Human IL-1α was cloned into pET15b and pET30a (Novagen) for His-tagging, or pGEX-4T-3 (GE) for GST-tagging, at residues 1-271 for p33 IL-1α or 119-271 for p17 IL-1α(Kobayashi et al., 1990) . Soluble human IL-1R2 (1-296) was cloned into pGEX-4T-3. For His purification, log-phase bacterial cultures were induced with IPTG (1mM) for 3h at 37°C, pelleted, and lysed in BugBuster (Novagen) with benzonase (100u/ml), lysozyme (100 U/ml) and protease inhibitors (10mins, RT).
Urea to 6 M was added and incubated (10 mins), before clarification and purification on a Ni 2+ column. Briefly, supernatant was adjusted to pH 7.5, applied to the column, washed with 40 mM imidazole, and eluted with 250 mM imidazole. Following concentration (Vivaspin) protein was dialyzed against decreasing concentrations of urea (4 M, 2 M) in 10 mM Tris pH 8.0, 50 mM NaCl, at 4°C for 3 h each, and overnight (0 M). For GST purification, cultures were induced with IPTG (1 mM) for 4h at RT, pelleted, and lysed in 50 mM Na 2 HPO 4 pH 7.5, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, with benzonase (100 U/ml), lysozyme (100 U/ml), protease inhibitors at RT for 30mins, clarified and applied to glutathione agarose (Qiagen), washed, eluted with 50 mM reduced glutathione, concentrated and dialyzed against 10 mM Tris pH 8.0, 50 mM NaCl, at 4°C overnight. The GST tag was removed with biotinylated thrombin (Novagen). Protein concentration was determined with a Pierce 660 protein assay (Thermo Scientific), checked for concentration and purity by Coomassie staining, and if necessary adjusted and rechecked. Proteins were stored in 10% glycerol at -80°C.
Protease cleavage
His-or GST-p33 IL-1α (20ng -2µg) was incubated in 10 mM Tris pH 7.5, 150 mM NaCl, 1 mM DTT, 2 mM CaCl 2 with purified human erythrocyte calpain (0.5-30 U; Calbiochem) in a final volume of 30 µl ± calpeptin (30 µM) or IL-1R2 (250ng) for 30 mins at RT. 'Calpain sham' reactions were assembled with calpain but without p33
IL-1α. IL-1R2 (250ng -2µg; R&D) was incubated with active caspase-1, 3, 4, 5 (1-10 U; Promokine) in 50 mM HEPES pH 7.2, 50 mM NaCl, 0.1% CHAPS, 10 mM EDTA, 5% Glycerol, and 10 mM DTT for 2 -16 h at 37°C. Cleaved IL-1R2 was dialyzed against DMEM before cell treatment. Jurkat necrotic lysates were also incubated with granzyme B (100 nM; Cambridge Bioscience), chymase or elastase (100 nM; both Enzo).
Cytokine release assay
VSMCs were plated at 1. Cytosolic HeLa cell extracts, made using the cytosol extraction buffer from the subcellular protein fractionation kit, were left untreated or treated with Triton X-100 (1%), Protease K (250µg/ml), or both, in an ice bath (30 mins). Protease inhibitor cocktail and PMSF (1mM) was added, followed by immediate boiling in Laemmli buffer.
RT-PCR
RNA was extracted using TRI-reagent, DNAse treated (Ambion) and reverse For intracellular-specific MFI the surface-specific value was subtracted.
Animal Protocols
Animal experiments were performed under UK Home Office licensing. Mice were injected intraperitoneally with saline or 0.29 fmol/g body weight of p17 or p33 IL-1α, or 8.3x10 4 necrotic HeLa cells. After 6 h, the peritoneal cavity was lavaged with 5ml of PBS. GR-1 +ve cells were enumerated by FACS following anti-GR-1-FITC staining (1:200; Biolegend).
Statistics
Parametric tests were employed for analysis of continuous ELISA and peritonitis data, which was conducted using a one-way, two-tailed ANOVA (Excel).
